GlassScriptPhysician profile
Christina Kwon
NPI 1841284023
$1,713.75
in general payments reported to CMS, 2019-2025
17 companies · $20.33 in 2025
The $20.33 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $857 · 2021: $39.96 · 2022: $188 · 2023: $180 · 2024: $428 · 2025: $20.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $696.47 | 2019-2024 | Altis |
| Astellas Pharma US INC | $199.13 | 2019 | |
| Abbvie INC. | $190.55 | 2019 | |
| Organon LLC | $116.80 | 2024 | |
| Axonics, INC. | $109.82 | 2023 | Bulkamid |
| Coopersurgical, INC. | $109.27 | 2019-2021 | |
| Daiichi Sankyo INC. | $79.46 | 2019 | |
| Renovia INC | $33.19 | 2019 | |
| Millicent US INC | $31.06 | 2019 | |
| Merck Sharp & Dohme LLC | $24.06 | 2019 | |
| Allergan, INC. | $20.61 | 2019 | |
| Galderma Laboratories, L.P. | $20.33 | 2025 | Nemluvio |
| Bayer Healthcare Pharmaceuticals INC. | $19.61 | 2019 | |
| Hologic Sales and Service, LLC | $18.75 | 2019 | |
| Amag Pharmaceuticals, INC. | $18.42 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $15.01 | 2019 | |
| Avion Pharmaceuticals | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.